ALPS
Price
$0.94
Change
-$0.02 (-2.08%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
164.72M
Intraday BUY SELL Signals
TCRX
Price
$0.96
Change
-$0.04 (-4.00%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
57.32M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPS vs TCRX

Header iconALPS vs TCRX Comparison
Open Charts ALPS vs TCRXBanner chart's image
Alps Group
Price$0.94
Change-$0.02 (-2.08%)
Volume$3.88K
Capitalization164.72M
TScan Therapeutics
Price$0.96
Change-$0.04 (-4.00%)
Volume$8.41K
Capitalization57.32M
ALPS vs TCRX Comparison Chart in %
ALPS
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALPS vs. TCRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPS is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ALPS: $0.96 vs. TCRX: $1.00)
Brand notoriety: ALPS and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPS: 95% vs. TCRX: 35%
Market capitalization -- ALPS: $164.72M vs. TCRX: $57.32M
ALPS [@Biotechnology] is valued at $164.72M. TCRX’s [@Biotechnology] market capitalization is $57.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPS’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • ALPS’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ALPS is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPS’s TA Score shows that 2 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • ALPS’s TA Score: 2 bullish, 4 bearish.
  • TCRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than ALPS.

Price Growth

ALPS (@Biotechnology) experienced а -1.83% price change this week, while TCRX (@Biotechnology) price change was -11.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPS($165M) has a higher market cap than TCRX($57.3M). ALPS YTD gains are higher at: 10.881 vs. TCRX (-0.420).
ALPSTCRXALPS / TCRX
Capitalization165M57.3M288%
EBITDAN/A-136.89M-
Gain YTD10.881-0.420-2,591%
P/E RatioN/AN/A-
RevenueN/A8.42M-
Total CashN/A184M-
Total DebtN/A95.6M-
TECHNICAL ANALYSIS
Technical Analysis
ALPSTCRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
14%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
10%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
19%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
48%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
25%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ALPS
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WFRSF2.670.34
+14.67%
West African Resources Ltd.
KGTFF0.92N/A
N/A
Krung Thai Bank Public Co., Ltd.
PUMXF0.17N/A
N/A
Puma Exploration, Inc.
ELLRY2.56N/A
N/A
Elringklinger Ag
TNCAF14.40N/A
N/A
TC Energy Corp.

ALPS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPS has been loosely correlated with APLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPS jumps, then APLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPS
1D Price
Change %
ALPS100%
-2.09%
APLS - ALPS
48%
Loosely correlated
+2.15%
ADTX - ALPS
26%
Poorly correlated
-9.66%
VNDA - ALPS
25%
Poorly correlated
+4.01%
VERU - ALPS
24%
Poorly correlated
-0.39%
TCRX - ALPS
23%
Poorly correlated
-2.37%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with BMEA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-2.37%
BMEA - TCRX
40%
Loosely correlated
+0.91%
SYRE - TCRX
39%
Loosely correlated
+1.65%
CRBU - TCRX
39%
Loosely correlated
+6.85%
BEAM - TCRX
38%
Loosely correlated
-0.11%
XNCR - TCRX
37%
Loosely correlated
-0.99%
More